Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group - Sanz, M A; Martín, G; González, M; Programa de Estudio y Traitmiento de las Hemopatías Malignas (Blood, 2004)